
Opinion|Videos|August 13, 2025
Deciding When to Treat Patients With Alopecia Areata
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on factors such as disease severity, patient symptoms, and the use of scoring systems to guide treatment decisions.
Advertisement
Episodes in this series

Video content above is prompted by the following:
McMichael: In which patients do you treat AA vs use observation? Is there a scoring system that you use?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk MM
4
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
5














































